This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2015 Mar 26;372(13):1260-1.

doi: 10.1056/NEJMe1500351. Epub 2015 Feb 18.

Treatment choice for diabetic macular edema

Daniel F Martin¹, Maureen G Maguire

Affiliations

PMID: 25692914
DOI: 10.1056/NEJMe1500351

Editorial

Treatment choice for diabetic macular edema

Daniel F Martin et al. N Engl J Med. 2015.

. 2015 Mar 26;372(13):1260-1.

doi: 10.1056/NEJMe1500351. Epub 2015 Feb 18.

Authors

Daniel F Martin¹, Maureen G Maguire

Affiliation

¹ From the Cleveland Clinic Cole Eye Institute, Cleveland (D.F.M.); and the Department of Ophthalmology, University of Pennsylvania, Philadelphia (M.G.M.).

PMID: 25692914
DOI: 10.1056/NEJMe1500351

No abstract available

PubMed Disclaimer

Comment in

Targeting the Effect of VEGF in Diabetic Macular Edema.
Nowroozzadeh MH. Nowroozzadeh MH. N Engl J Med. 2015 Jul 30;373(5):481. doi: 10.1056/NEJMc1505684. N Engl J Med. 2015. PMID: 26222569 No abstract available.
Targeting the Effect of VEGF in Diabetic Macular Edema.
Martin DF, Maguire MG. Martin DF, et al. N Engl J Med. 2015 Jul 30;373(5):482. doi: 10.1056/NEJMc1505684. N Engl J Med. 2015. PMID: 26230004 No abstract available.

Comment on

Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
Diabetic Retinopathy Clinical Research Network; Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW. Diabetic Retinopathy Clinical Research Network, et al. N Engl J Med. 2015 Mar 26;372(13):1193-203. doi: 10.1056/NEJMoa1414264. Epub 2015 Feb 18. N Engl J Med. 2015. PMID: 25692915 Free PMC article. Clinical Trial.

Similar articles

Targeting the Effect of VEGF in Diabetic Macular Edema.
Martin DF, Maguire MG. Martin DF, et al. N Engl J Med. 2015 Jul 30;373(5):482. doi: 10.1056/NEJMc1505684. N Engl J Med. 2015. PMID: 26230004 No abstract available.
Targeting the Effect of VEGF in Diabetic Macular Edema.
Nowroozzadeh MH. Nowroozzadeh MH. N Engl J Med. 2015 Jul 30;373(5):481. doi: 10.1056/NEJMc1505684. N Engl J Med. 2015. PMID: 26222569 No abstract available.
Targeting the Effect of VEGF in Diabetic Macular Edema.
Adamis AP, Ehrlich J, Fung A. Adamis AP, et al. N Engl J Med. 2015 Jul 30;373(5):480-1. doi: 10.1056/NEJMc1505684. N Engl J Med. 2015. PMID: 26222568 No abstract available.
Anti-VEGF Molecules for the Management of Diabetic Macular Edema.
Bandello F, Cicinelli MV, Parodi MB. Bandello F, et al. Curr Pharm Des. 2015;21(32):4731-7. doi: 10.2174/1381612821666150909095756. Curr Pharm Des. 2015. PMID: 26350530 Review.
Comparative effectiveness of anti-growth factor therapies for diabetic macular edema: summary of primary findings and conclusions.
O'Malley PG. O'Malley PG. Arch Intern Med. 2012 Jul 9;172(13):1014-5. doi: 10.1001/archinternmed.2012.2335. Arch Intern Med. 2012. PMID: 22688778 Review. No abstract available.

See all similar articles

Cited by

Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline.
LeRoith D, Biessels GJ, Braithwaite SS, Casanueva FF, Draznin B, Halter JB, Hirsch IB, McDonnell ME, Molitch ME, Murad MH, Sinclair AJ. LeRoith D, et al. J Clin Endocrinol Metab. 2019 May 1;104(5):1520-1574. doi: 10.1210/jc.2019-00198. J Clin Endocrinol Metab. 2019. PMID: 30903688 Free PMC article.
Changes in retinal and choriocapillaris density in diabetic patients receiving anti-vascular endothelial growth factor treatment using optical coherence tomography angiography.
Conti FF, Song W, Rodrigues EB, Singh RP. Conti FF, et al. Int J Retina Vitreous. 2019 Dec 10;5:41. doi: 10.1186/s40942-019-0192-9. eCollection 2019. Int J Retina Vitreous. 2019. PMID: 31867124 Free PMC article.
Ophthalmic community perception of new medication needs.
Stewart WC, Stewart JA, Nelson LA. Stewart WC, et al. Int J Ophthalmol. 2018 May 18;11(5):848-851. doi: 10.18240/ijo.2018.05.22. eCollection 2018. Int J Ophthalmol. 2018. PMID: 29862187 Free PMC article.
Off-label use of targeted therapies in oncology.
Levêque D. Levêque D. World J Clin Oncol. 2016 Apr 10;7(2):253-7. doi: 10.5306/wjco.v7.i2.253. World J Clin Oncol. 2016. PMID: 27081648 Free PMC article. Review.
Protective Factors and the Pathogenesis of Complications in Diabetes.
Yu MG, Gordin D, Fu J, Park K, Li Q, King GL. Yu MG, et al. Endocr Rev. 2024 Mar 4;45(2):227-252. doi: 10.1210/endrev/bnad030. Endocr Rev. 2024. PMID: 37638875 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information